BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12625854)

  • 1. A comparative analysis of rapid urine tests for the diagnosis of upper urinary tract malignancy.
    Siemens DR; Morales A; Johnston B; Emerson L
    Can J Urol; 2003 Feb; 10(1):1754-8. PubMed ID: 12625854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of screening methods in the detection of bladder cancer.
    Ramakumar S; Bhuiyan J; Besse JA; Roberts SG; Wollan PC; Blute ML; O'Kane DJ
    J Urol; 1999 Feb; 161(2):388-94. PubMed ID: 9915409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder.
    Ianari A; Sternberg CN; Rossetti A; Van Rijn A; Deidda A; Giannarelli D; Pansadoro V
    Urology; 1997 May; 49(5):786-9. PubMed ID: 9145993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dilemma of suspicious urine cytology in patients being followed for bladder cancer.
    Raitanen MP; Aine R; Kylmälä T; Kallio J; Liukkonen T; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):256-9. PubMed ID: 11820413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bladder tumor antigen test versus urinary cytology in patients with bladder tumors].
    Gregersen B; Mommsen S; Svanholm H
    Ugeskr Laeger; 1999 Apr; 161(14):2071-3. PubMed ID: 10354792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer.
    D'Hallewin MA; Baert L
    J Urol; 1996 Feb; 155(2):475-6. PubMed ID: 8558639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bard BTA test compared with voided urine cytology in the diagnosis of recurrent bladder cancer.
    Leyh H; Mazeman E
    Eur Urol; 1997; 32(4):425-8. PubMed ID: 9412800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of BTA Stat test (Bard) in the diagnosis of bladder cancer. Preliminary results and comparison with cytology and cystoscopy].
    Gutiérrez Baños JL; Martín García B; Hernández Rodríguez R; Portillo Martín JA; Correas Gómez MA; del Valle Schaan JI; Roca Edreira A; Villanueva Peña A; Gutíerrez García R; De Diego Rodríguez E; Rado Velázquez MA
    Arch Esp Urol; 1998 Oct; 51(8):778-82. PubMed ID: 9859583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New diagnostic tests for urothelial tumors of the bladder].
    Irani J
    Prog Urol; 1998 Sep; 8(4):481-6. PubMed ID: 9834508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of bladder cancer: a comparative study of point of care tests.
    Johnston B; Morales A; Emerson L; Lundie M
    J Urol; 1997 Dec; 158(6):2098-101. PubMed ID: 9366321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor bladder antigen (TBA). A new method for the diagnosis and detection of recurrence of bladder cancer].
    Escaf Barmadah S; Martín Benito JL; Fernández Gómez JM; San Martín Blanco A; Pérez Gracia FJ; Rodríguez Martínez JJ
    Arch Esp Urol; 1998 Mar; 51(2):129-36. PubMed ID: 9586309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Bard BTA test with voided urine and bladder wash cytology in the diagnosis and management of cancer of the bladder.
    Leyh H; Hall R; Mazeman E; Blumenstein BA
    Urology; 1997 Jul; 50(1):49-53. PubMed ID: 9218018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
    Halling KC; King W; Sokolova IA; Karnes RJ; Meyer RG; Powell EL; Sebo TJ; Cheville JC; Clayton AC; Krajnik KL; Ebert TA; Nelson RE; Burkhardt HM; Ramakumar S; Stewart CS; Pankratz VS; Lieber MM; Blute ML; Zincke H; Seelig SA; Jenkins RB; O'Kane DJ
    J Urol; 2002 May; 167(5):2001-6. PubMed ID: 11956427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma.
    Hakenberg OW; Fuessel S; Richter K; Froehner M; Oehlschlaeger S; Rathert P; Meye A; Wirth MP
    Urology; 2004 Dec; 64(6):1121-6. PubMed ID: 15596183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
    Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A
    Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization for detecting upper urinary tract tumors--a preliminary report.
    Akkad T; Brunner A; Pallwein L; Gozzi C; Bartsch G; Mikuz G; Steiner H; Verdorfer I
    Urology; 2007 Oct; 70(4):753-7. PubMed ID: 17991550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTA TRAK urine test increases the efficacy of cytology in the diagnosis of low-grade transitional cell carcinoma of the bladder.
    Gibanel R; Ribal MJ; Filella X; Ballesta AM; Molina R; Alcaraz A; Alcover JB
    Anticancer Res; 2002; 22(2B):1157-60. PubMed ID: 12168917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.